227 related articles for article (PubMed ID: 17483544)
61. Inhibition of squalene synthase upregulates PCSK9 expression in rat liver.
Bedi M; Niesen M; Lopez D
Arch Biochem Biophys; 2008 Feb; 470(2):116-9. PubMed ID: 18054775
[TBL] [Abstract][Full Text] [Related]
62. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol.
Bostedor RG; Karkas JD; Arison BH; Bansal VS; Vaidya S; Germershausen JI; Kurtz MM; Bergstrom JD
J Biol Chem; 1997 Apr; 272(14):9197-203. PubMed ID: 9083051
[TBL] [Abstract][Full Text] [Related]
63. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
64. Lead nitrate-induced development of hypercholesterolemia in rats: sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis.
Kojima M; Masui T; Nemoto K; Degawa M
Toxicol Lett; 2004 Dec; 154(1-2):35-44. PubMed ID: 15475176
[TBL] [Abstract][Full Text] [Related]
65. Discovery of Potential Inhibitors of Squalene Synthase from Traditional Chinese Medicine Based on Virtual Screening and In Vitro Evaluation of Lipid-Lowering Effect.
Chen Y; Chen X; Luo G; Zhang X; Lu F; Qiao L; He W; Li G; Zhang Y
Molecules; 2018 Apr; 23(5):. PubMed ID: 29710800
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine.
Ward WH; Holdgate GA; Freeman S; McTaggart F; Girdwood PA; Davidson RG; Mallion KB; Brown GR; Eakin MA
Biochem Pharmacol; 1996 Jun; 51(11):1489-501. PubMed ID: 8630090
[TBL] [Abstract][Full Text] [Related]
67. Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.
Shidoji Y; Tabata Y
J Lipid Res; 2019 Mar; 60(3):579-593. PubMed ID: 30622150
[TBL] [Abstract][Full Text] [Related]
68. Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor.
Kocarek TA; Mercer-Haines NA
Mol Pharmacol; 2002 Nov; 62(5):1177-86. PubMed ID: 12391282
[TBL] [Abstract][Full Text] [Related]
69. Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.
Fulton DC; Tait M; Threlfall DR
Phytochemistry; 1995 Mar; 38(5):1137-41. PubMed ID: 7766395
[TBL] [Abstract][Full Text] [Related]
70. Branch Pathway Blocking in Artemisia annua is a Useful Method for Obtaining High Yield Artemisinin.
Lv Z; Zhang F; Pan Q; Fu X; Jiang W; Shen Q; Yan T; Shi P; Lu X; Sun X; Tang K
Plant Cell Physiol; 2016 Mar; 57(3):588-602. PubMed ID: 26858285
[TBL] [Abstract][Full Text] [Related]
71. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
[TBL] [Abstract][Full Text] [Related]
72. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
73. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor.
Vukelic S; Stojadinovic O; Pastar I; Vouthounis C; Krzyzanowska A; Das S; Samuels HH; Tomic-Canic M
J Biol Chem; 2010 Jan; 285(3):1980-8. PubMed ID: 19903814
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death.
Michikawa M; Yanagisawa K
J Neurochem; 1999 Jun; 72(6):2278-85. PubMed ID: 10349836
[TBL] [Abstract][Full Text] [Related]
75. Molecular consequences of altered neuronal cholesterol biosynthesis.
Korade Z; Kenworthy AK; Mirnics K
J Neurosci Res; 2009 Mar; 87(4):866-75. PubMed ID: 18951487
[TBL] [Abstract][Full Text] [Related]
76. The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.
Lanterna C; Musumeci A; Raccosta L; Corna G; Moresco M; Maggioni D; Fontana R; Doglioni C; Bordignon C; Traversari C; Russo V
Cancer Immunol Immunother; 2016 Nov; 65(11):1303-1315. PubMed ID: 27520505
[TBL] [Abstract][Full Text] [Related]
77. Biological activities of novel zaragozic acids, the potent inhibitors of squalene synthase, produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Hamano K; Onodera K; Hosoya T; Kakusaka M; Hirayama T; Shimada Y; Koga T; Tsujita Y
J Antibiot (Tokyo); 1997 May; 50(5):390-4. PubMed ID: 9207908
[TBL] [Abstract][Full Text] [Related]
78. The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Ravid T; Doolman R; Avner R; Harats D; Roitelman J
J Biol Chem; 2000 Nov; 275(46):35840-7. PubMed ID: 10964918
[TBL] [Abstract][Full Text] [Related]
79. Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition.
Biftu T; Acton JJ; Berger GD; Bergstrom JD; Dufresne C; Kurtz MM; Marquis RW; Parsons WH; Rew DR; Wilson KE
J Med Chem; 1994 Feb; 37(3):421-4. PubMed ID: 8308869
[TBL] [Abstract][Full Text] [Related]
80. A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes.
Gardner RG; Hampton RY
J Biol Chem; 1999 Oct; 274(44):31671-8. PubMed ID: 10531376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
